06:18 AM EST, 02/27/2025 (MT Newswires) -- Verona Pharma ( VRNA ) reported a Q4 loss Thursday of $0.05 per diluted share, compared with a loss of $0.02 a year earlier.

Analysts polled by FactSet expected a loss of $0.19.

Revenue for the quarter ended Dec. 31 was $36.7 million. The company did not report any revenue in the year-ago quarter.

Analysts surveyed by FactSet expected $33 million.

As of Dec. 31, the biopharmaceutical firm reported $399.8 million in cash and cash equivalents.

Shares of the company rose nearly 4% in recent premarket activity.

Price: 66.00, Change: +2.48, Percent Change: +3.90